Wellington Management Group
ODT

Wellington Management Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Wellington Management Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,771,744
Closed -$72.4M – 2238
2020
Q4 		$72.4M Sell
3,771,744
-764,775
-17% -$11.8M 0.01% 673
2020
Q3 		$60.9M Buy
4,536,519
+2,555,217
+129% +$72.4M 0.01% 644
2020
Q2 		$83.9M Buy
1,981,302
+94,896
+5% +$3.07M 0.02% 566
2020
Q1 		$52.1M Sell
1,886,406
-175,015
-8% -$5.1M 0.01% 626
2019
Q4 		$66.9M Buy
2,061,421
+11,335
+0.6% +$351K 0.01% 684
2019
Q3 		$53.4M Sell
2,050,086
-58,832
-3% -$1.97M 0.01% 711
2019
Q2 		$77.4M Buy
+2,108,918
New +$50.5M 0.02% 631

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Wellington Management Group's ODT Position: Q1 2021 in Review

Wellington Management Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 3,771,744 shares — an estimated $72.4M sold.

Wellington Management Group first reported a position in ODT in Q2 2019 and held it in 7 quarters. The position peaked at $83.9M in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Wellington Management Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Wellington Management Group sold 3,771,744 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $72.4M.
  • Wellington Management Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Wellington Management Group's Odonate Therapeutics, Inc. Common Stock position peaked at $83.9M in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Wellington Management Group's 13F filing for Q1 2021, filed 17 May 2021.